These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44 related articles for article (PubMed ID: 26928019)
1. Discovery of BI-9508, a Brain-Penetrant GPR88-Receptor-Agonist Tool Compound for Fer M; Amalric C; Arban R; Baron L; Ben Hamida S; Breh-Schlanser P; Cui Y; Darcq E; Eickmeier C; Faye V; Franchet C; Frauli M; Halter C; Heyer M; Hoenke C; Hoerer S; Hucke OT; Joseph C; Kieffer BL; Lebrun L; Lotz N; Mayer S; Omrani A; Recolet M; Schaeffer L; Schann S; Schlecker A; Steinberg E; Viloria M; Würstle K; Young K; Zinser A; Montel F; Klepp J J Med Chem; 2024 Jul; 67(13):11296-11325. PubMed ID: 38949964 [TBL] [Abstract][Full Text] [Related]
2. Discovery of novel pyrrole-based scaffold as potent and orally bioavailable free fatty acid receptor 1 agonists for the treatment of type 2 diabetes. Li Z; Pan M; Su X; Dai Y; Fu M; Cai X; Shi W; Huang W; Qian H Bioorg Med Chem; 2016 May; 24(9):1981-7. PubMed ID: 27020683 [TBL] [Abstract][Full Text] [Related]
3. Development and Characterization of a Potent Free Fatty Acid Receptor 1 (FFA1) Fluorescent Tracer. Christiansen E; Hudson BD; Hansen AH; Milligan G; Ulven T J Med Chem; 2016 May; 59(10):4849-58. PubMed ID: 27074625 [TBL] [Abstract][Full Text] [Related]
4. Structural basis for the cooperative allosteric activation of the free fatty acid receptor GPR40. Lu J; Byrne N; Wang J; Bricogne G; Brown FK; Chobanian HR; Colletti SL; Di Salvo J; Thomas-Fowlkes B; Guo Y; Hall DL; Hadix J; Hastings NB; Hermes JD; Ho T; Howard AD; Josien H; Kornienko M; Lumb KJ; Miller MW; Patel SB; Pio B; Plummer CW; Sherborne BS; Sheth P; Souza S; Tummala S; Vonrhein C; Webb M; Allen SJ; Johnston JM; Weinglass AB; Sharma S; Soisson SM Nat Struct Mol Biol; 2017 Jul; 24(7):570-577. PubMed ID: 28581512 [TBL] [Abstract][Full Text] [Related]
5. A Molecular Mechanism for Sequential Activation of a G Protein-Coupled Receptor. Grundmann M; Tikhonova IG; Hudson BD; Smith NJ; Mohr K; Ulven T; Milligan G; Kenakin T; Kostenis E Cell Chem Biol; 2016 Mar; 23(3):392-403. PubMed ID: 26991104 [TBL] [Abstract][Full Text] [Related]
7. Metabolism meets immunity: The role of free fatty acid receptors in the immune system. Alvarez-Curto E; Milligan G Biochem Pharmacol; 2016 Aug; 114():3-13. PubMed ID: 27002183 [TBL] [Abstract][Full Text] [Related]
8. Diverse effects of G-protein-coupled free fatty acid receptors on the regulation of cellular functions in lung cancer cells. Kita T; Kadochi Y; Takahashi K; Fukushima K; Yamasaki E; Uemoto T; Hirane M; Fukushima N; Honoki K; Tsujiuchi T Exp Cell Res; 2016 Mar; 342(2):193-9. PubMed ID: 26968637 [TBL] [Abstract][Full Text] [Related]
9. GPR40 agonist ameliorates liver X receptor-induced lipid accumulation in liver by activating AMPK pathway. Li M; Meng X; Xu J; Huang X; Li H; Li G; Wang S; Man Y; Tang W; Li J Sci Rep; 2016 Apr; 6():25237. PubMed ID: 27121981 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of GPR40/FFAR1 agonists containing 3,5-dimethylisoxazole. Yang L; Zhang J; Si L; Han L; Zhang B; Ma H; Xing J; Zhao L; Zhou J; Zhang H Eur J Med Chem; 2016 Jun; 116():46-58. PubMed ID: 27054485 [TBL] [Abstract][Full Text] [Related]
11. Targeting of free fatty acid receptor 1 in EOC: A novel strategy to restrict the adipocyte-EOC dependence. Munkarah A; Mert I; Chhina J; Hamid S; Poisson L; Hensley-Alford S; Giri S; Rattan R Gynecol Oncol; 2016 Apr; 141(1):72-9. PubMed ID: 27016232 [TBL] [Abstract][Full Text] [Related]
12. GPR40 receptor activation leads to CREB phosphorylation and improves cognitive performance in an Alzheimer's disease mouse model. Khan MZ; Zhuang X; He L Neurobiol Learn Mem; 2016 May; 131():46-55. PubMed ID: 26976092 [TBL] [Abstract][Full Text] [Related]
14. Discovery of a Potent Free Fatty Acid 1 Receptor Agonist with Low Lipophilicity, Low Polar Surface Area, and Robust in Vivo Efficacy. Hansen SV; Christiansen E; Urban C; Hudson BD; Stocker CJ; Due-Hansen ME; Wargent ET; Shimpukade B; Almeida R; Ejsing CS; Cawthorne MA; Kassack MU; Milligan G; Ulven T J Med Chem; 2016 Mar; 59(6):2841-6. PubMed ID: 26928019 [TBL] [Abstract][Full Text] [Related]
15. Identification of a potent and selective free fatty acid receptor 1 (FFA1/GPR40) agonist with favorable physicochemical and in vitro ADME properties. Christiansen E; Urban C; Grundmann M; Due-Hansen ME; Hagesaether E; Schmidt J; Pardo L; Ullrich S; Kostenis E; Kassack M; Ulven T J Med Chem; 2011 Oct; 54(19):6691-703. PubMed ID: 21854074 [TBL] [Abstract][Full Text] [Related]
16. Discovery of novel free fatty acid receptor 1 agonists bearing triazole core via click chemistry. Li Z; Yang J; Wang X; Li H; Liu C; Wang N; Huang W; Qian H Bioorg Med Chem; 2016 Nov; 24(21):5449-5454. PubMed ID: 27624524 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and Structure-activity relationship studies of new thiazole-based free fatty acid receptor 1 agonists for the treatment of type 2 diabetes. Li Z; Qiu Q; Xu X; Wang X; Jiao L; Su X; Pan M; Huang W; Qian H Eur J Med Chem; 2016 May; 113():246-57. PubMed ID: 26945112 [TBL] [Abstract][Full Text] [Related]
18. Recent Updates on Free Fatty Acid Receptor 1 (GPR-40) Agonists for the Treatment of Type 2 Diabetes Mellitus. Rani L; Grewal AS; Sharma N; Singh S Mini Rev Med Chem; 2021; 21(4):426-470. PubMed ID: 33100202 [TBL] [Abstract][Full Text] [Related]